Catalog No. :
|
CL1229 |
Product Name :
|
Daunorubicin Hydrochloride |
CAS No. :
|
23541-50-6 |
Synonyms :
|
Daunomycin hydrochloride | RP 13057 hydrochloride | Rubidomycin hydrochloride |
Chemical Name :
|
(8S,10S)-8-acetyl-10-(((2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride. |
Molecular Formula :
|
C27H29NO10 . HCl |
Molecular Weight :
|
563.98 |
Molecular Structure :
|
|
Appearance :
|
Pink to red solid |
Specification :
|
99+% |
Application :
|
Antineoplastic Agents | Antineoplastic and Immunosuppressive Antibiotics inhibitor | Topoisomerase inhibitor | ADC Cytotoxin | COVID-19 inhibitor | DNA/RNA Synthesis inhibitor | Apoptosis related activator |
Registration :
|
|
Storage Condition :
|
ry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Daunorubicin HCl inhibits both DNA and RNA
synthesis and inhibits DNA synthesis with Ki of
0.02 μM in a cell-free assay. Daunorubicin is a topoisomerase
II inhibitor that induces apoptosis.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.